欧洲五国中重度银屑病成人心血管合并症与银屑病关节炎的增量负担
基于2010-2013年EU5国家健康与健康调查,957例中重度银屑病患者中19.8%报告心血管合并症、12.3%报告银屑病关节炎。调整协变量后,心血管合并症与心理健康评分低3.0分、躯体健康评分低3.4分、SF-6D低0.05分相关(均P<0.01),并伴随更高工作/活动受损和医疗资源使用。银屑病关节炎同样与显著增量负担相关。
要点
- 中重度银屑病患者中心血管合并症与银屑病关节炎分别占19.8%和12.3%。
- 心血管合并症与心理健康评分低3.0分、躯体健康评分低3.4分相关(均P<0.01)。
- 银屑病关节炎与躯体健康评分低6.3分及更高工作受损相关(P<0.05)。
核心结论
- 在EU5中重度银屑病成人中,心血管合并症和银屑病关节炎均与显著增量负担相关。
研究设计与样本
- 基于2010-2013年EU5国家健康与健康调查(NHWS)的自报数据,纳入957例中重度银屑病成人。
- 中重度银屑病定义为体表面积受累>10%和/或使用中重度疾病治疗。
- 采用广义线性模型比较心血管合并症或银屑病关节炎组 vs 无相应合并症组,并调整协变量。
主要发现
- 心血管合并症组心理健康评分低3.0分、躯体健康评分低3.4分、SF-6D低0.05分(均P<0.01)。
- 心血管合并症组平均工作受损48% vs 33%、活动受损48% vs 37%(均P<0.05)。
- 心血管合并症组医疗提供者就诊8.8 vs 6.9次、急诊就诊0.65 vs 0.31次、住院0.61 vs 0.22次(均P<0.05)。
- 银屑病关节炎组心理健康评分低2.6分、躯体健康评分低6.3分、SF-6D低0.07分(均P<0.05)。
- 银屑病关节炎组工作受损52% vs 34%、活动受损54% vs 38%、医疗提供者就诊10.5 vs 6.9次(均P<0.05)。
临床怎么用
- 对中重度银屑病患者应评估心血管合并症和银屑病关节炎,因其与健康相关生活质量及工作活动受损的增量负担相关。
局限性
- 所有测量均为自我报告,中重度银屑病基于体表面积和治疗使用定义。
- 数据来自2010-2013年调查,可能不反映当前实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Moderate-to-severe psoriasis is associated with reduced health-related quality of life (HRQoL). Individuals with psoriasis are at increased risk for other medical conditions, but little information quantifies the incremental burden of psoriasis-associated comorbidity among European adults, and data have generally been limited to clinical samples. OBJECTIVE: To quantify the incremental burden of cardiovascular comorbidity and psoriatic arthritis among adults with moderate-to-severe psoriasis in the general population of France, Germany, Italy, Spain and the United Kingdom (EU5). METHODS: All measures were self-reported and came from the 2010-2013 EU5 National Health and Wellness Surveys (NHWS). Moderate-to-severe psoriasis was identified by >10% body surface area affected by psoriasis and/or use of therapies for moderate-severe disease. Outcomes were SF-12v2/SF-36v2 mental and physical component summary scores (MCS and PCS, respectively), SF-6D health utility, Work Productivity and Activity Impairment (WPAI) questionnaire and healthcare use in the past 6 months. Generalized linear models compared across cardiovascular comorbidity (CV) or psoriatic arthritis (PsA) groups vs. non-CV or non-PsA groups with appropriate link functions to adjust for covariates. RESULTS: Among moderate-to-severe psoriasis respondents (n = 957), 19.8% (n = 190) reported CV comorbidity and 12.3% (n = 118) reported PsA. After adjustment for covariates, CV comorbidity was associated with 3.0 points lower MCS, 3.4 points lower PCS and 0.05 points lower SF-6D (all P < 0.01). Likewise, they had greater mean work impairment (48% vs. 33%), more activity impairment (48% vs. 37%), and more healthcare provider visits (8.8 vs. 6.9), emergency room visits (0.65 vs. 0.31) and hospitalizations (0.61 vs. 0.22) (all P < 0.05). Compared to non-PsA respondents, PsA respondents also had worse mean MCS (2.6 points), PCS (6.3 points) and SF-6D scores (0.07 points), and more work impairment (52% vs. 34%), activity impairment (54% vs. 38%) and healthcare provider visits (10.5 vs. 6.9) (all P < 0.05). CONCLUSION: CV comorbidity and PsA were associated with significant incremental burden among EU5 adults with moderate-to-severe psoriasis.
引用
- Augustin M, Vietri J, Tian H, et al. Incremental burden of cardiovascular comorbidity and psoriatic arthritis among adults with moderate-to-severe psoriasis in five European countries. J Eur Acad Dermatol Venereol. 2017. PMID: 28426138. doi:10.1111/jdv.14286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。